A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-0974 in Participants with Myelofibrosis or Myelodysplastic Syndrome and Anemia

Protocol No

DISC-0974-102

Staff Member

Laura Michaelis

Phase

I/II

Summary

This project is being done to investigate the safety and tolerability [whether side effects
can be handled by a participant] of DISC-0974 in participants with myelofibrosis and anemia

Objective

Phase 1-2 DISC-0974 in Myelofibrosis and Anemia

Study Sites

Froedtert Hospital

Status

OPEN TO ACCRUAL